Compulsory Licensing in Pharma Patents: A Win-Win Solution or a threat to innovation?
Is compulsory licensing in pharma patents the key to affordable medicines or a roadblock to innovation? This blog tackles this contentious debate, examining past cases, the WTO’s TRIPS Agreement, and the impact on global health using AI patent search and patent analysis.
Compulsory Licensing in Pharma Patents: A Win-Win Solution or a threat to innovation? Read More »